(20 days)
Not Found
No
The summary describes a physical implant system for spinal fusion, focusing on its material, design, and mechanical properties. There is no mention of software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
The device is described as an "anterior cervical interbody fusion system" intended to treat "degenerative disc disease" and provide "surgical stabilization of the spine," which are therapeutic actions.
No
The NEXXT MATRIXX® Stand Alone Cervical-TL System is an implantable surgical device used for interbody fusion, not for diagnosing conditions. Its purpose is to treat degenerative disc disease by providing surgical stabilization and supporting bone graft.
No
The device description explicitly states it is a collection of additively manufactured implants, including spacers and fixation screws, which are physical hardware components.
Based on the provided information, the NEXXT MATRIXX® Stand Alone Cervical-TL System is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for spinal fusion. It is used in the body to treat a physical condition (degenerative disc disease).
- Device Description: The device is described as an implantable system consisting of spacers and screws. These are physical components designed to be surgically placed within the patient.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue) outside of the body to provide information about a patient's health. IVD devices are used for diagnosis, monitoring, or screening based on analysis of biological samples.
Therefore, the NEXXT MATRIXX® Stand Alone Cervical-TL System is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The NEXXT MATRIXX® Stand Alone Cervical-TL System is a stand-alone anterior cervical interbody fusion system intended for use as an adjunct to fusion at one or two contiguous levels (C2-T1) in skeletally mature patients for the treatment of degenerative disc disease (defined as discogenic neck pain with degeneration of the disc confirmed by history and radiographic studies). These patients should have received at least six weeks of nonoperative treatment prior to treatment with the device. The NEXXT MATRIXX® Stand Alone Cervical-TL System is to be used with autograft bone graft and/or allogeneic bone graft composed of cancellous bone and implanted via and implanted via an open, anterior approach. The NEXXT MATRIXX® Stand Alone Cervical-TL System is intended to be used with the bone screw fixation provided and requires no additional fixation.
Product codes (comma separated list FDA assigned to the subject device)
OVE
Device Description
NEXXT MATRIXX® is a collection of additively manufactured implants. The Stand Alone Cervical-TL System includes additively manufactured spacer and traditionally machined fixation screw implants. The spacer and screw components are available in an assortment of dimensional combinations to accommodate the individual anatomic and clinical circumstances of each patient.
The basic shape of the spacer is a structural column to provide surgical stabilization of the spine. Each device comprises an external structural frame having a roughened surface (~7 µm). The intervening geometric lattices have 300-700um pores. The inferior/superior aspects of the spacer incorporates a vertical cavity which can be packed with bone graft material. Each interbody is preassembled with a turn lock mechanism which secures the screw to the spacer component.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cervical, C2-T1
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The modified Stand Alone Cervical-TL device components were evaluated via dimensional analyses. The results demonstrated the performance of the modified Stand Alone Cervical-TL device is substantially equivalent to the predicate. In addition, the screw pushout properties for the modified Stand Alone Cervical-TL construct were evaluated.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
Image /page/0/Picture/0 description: The image shows the logo for the U.S. Food & Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services seal on the left and the FDA acronym followed by the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a solid blue square and the agency name in a lighter blue. The text reads "FDA U.S. FOOD & DRUG ADMINISTRATION".
March 23, 2020
Nexxt Spine, LLC % Karen E. Warden, Ph.D. President BackRoads Consulting Inc. P.O. Box 566 Chesterland, Ohio 44026
Re: K200543
Trade/Device Name: NEXXT MATRIXX® Stand Alone Cervical-Turn Lock (-TL) System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: OVE Dated: March 2, 2020 Received: March 3, 2020
Dear Dr. Warden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Brent Showalter, Ph.D. Assistant Director (Acting) DHT6B: Division of Spinal Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name
NEXXT MATRIXX® Stand Alone Cervical-Turn Lock (-TL) System
Indications for Use (Describe)
The NEXXT MATRIXX® Stand Alone Cervical-TL System is a stand-alone anterior cervical interbody fusion system intended for use as an adjunct to fusion at one or two contiguous levels (C2-T1) in skeletally mature patients for the treatment of degenerative disc disease (defined as discogenic neck pain with degeneration of the disc confirmed by history and radiographic studies). These patients should have received at least six weeks of nonoperative treatment prior to treatment with the device. The NEXXT MATRIXX® Stand Alone Cervical-TL System is to be used with autograft bone graft and/or allogeneic bone graft composed of cancellous bone and implanted via and implanted via an open, anterior approach. The NEXXT MATRIXX® Stand Alone Cervical-TL System is intended to be used with the bone screw fixation provided and requires no additional fixation.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Section 7 – 510(k) Summary
| Date: | 2 March 2020 |
|---|---|
| Sponsor: | Nexxt Spine, LLC |
| 14425 Bergen Blvd, Suite B | |
| Noblesville, IN 46060 | |
| Office: 317.436.7801 | |
| Fax: 317.245.2518 | |
| Sponsor Contact: | Andy Elsbury, President |
| 510(k) Contact: | Karen E. Warden, PhD |
| BackRoads Consulting Inc. | |
| PO Box 566 | |
| Chesterland, OH 44026 | |
| Office: 440.729.8457 | |
| Proposed Trade Name: | NEXXT MATRIXX® Stand Alone Cervical-Turn Lock (-TL) System |
| Common Name: | Cervical spacer with integrated fixation |
| Device Classification: | Class II |
| Regulation Name, | |
| Regulation Number, | |
| Product Code: | Intervertebral fusion device with integrated fixation, cervical, 888.3080, OVE |
| Submission Purpose: | The subject 510(k) adds an line of implants having an alternative screw |
| retention feature to the NEXXT MATRIXX® Stand Alone Cervical System. | |
| Device Description: | NEXXT MATRIXX® is a collection of additively manufactured implants. The |
| Stand Alone Cervical-TL System includes additively manufactured spacer | |
| and traditionally machined fixation screw implants. The spacer and screw | |
| components are available in an assortment of dimensional combinations to | |
| accommodate the individual anatomic and clinical circumstances of each | |
| patient. | |
| The basic shape of the spacer is a structural column to provide surgical | |
| stabilization of the spine. Each device comprises an external structural | |
| frame having a roughened surface (~7 µm). The intervening geometric | |
| lattices have 300-700um pores. The inferior/superior aspects of the spacer | |
| incorporates a vertical cavity which can be packed with bone graft material. | |
| Each interbody is preassembled with a turn lock mechanism which secures | |
| the screw to the spacer component. | |
| Indications for Use: | The NEXXT MATRIXX® Stand Alone Cervical-TL System is a stand-alone |
| anterior cervical interbody fusion system intended for use as an adjunct to | |
| fusion at one or two contiguous levels (C2-T1) in skeletally mature patients | |
| for the treatment of degenerative disc disease (defined as discogenic neck | |
| pain with degeneration of the disc confirmed by history and radiographic | |
| studies). These patients should have received at least six weeks of | |
| nonoperative treatment prior to treatment with the device. The NEXXT | |
| MATRIXX® Stand Alone Cervical-TL System is to be used with autograft | |
| bone graft and/or allogeneic bone graft composed of cancellous and/or | |
| corticocancellous bone and implanted via an open, anterior approach. The | |
| NEXXT MATRIXX® Stand Alone Cervical-TL System is intended to be used | |
| with the bone screw fixation provided and requires no additional fixation | |
| Materials: | NEXXT MATRIXX® Stand Alone Cervical System spacers are manufactured |
| from Ti-6Al-4V ELI titanium alloy per ASTM F3001. The fixation screws and | |
| turn lock components are manufactured from Ti-6AI-4V ELI titanium alloy | |
| per ASTM F136. |
4
| Primary Predicate: | NEXXT MATRIXX® Stand Alone Cervical System (Nexxt Spine, LLC – K190546) |
|---|---|
| Performance Data: | The modified Stand Alone Cervical-TL device components were evaluated via dimensional analyses. The results demonstrated the performance of the modified Stand Alone Cervical-TL device is substantially equivalent to the predicate. In addition, the screw pushout properties for the modified Stand Alone Cervical-TL construct were evaluated. |
| Technological Characteristics: | The modified Stand Alone Cervical-TL device possesses the same technological characteristics as one or more of the predicate devices. These include: performance (as described above), basic design (additively manufactured structure and integrated fixation), material (titanium alloy) and size (dimensions are comparable to those offered by the cleared devices). Therefore the fundamental scientific technology of the modified Stand Alone Cervical-TL device is the same as previously cleared devices. |
| Conclusion: | The modified Stand Alone Cervical-TL System possesses the same intended use and technological characteristics as the predicate devices. Therefore the modified Stand Alone Cervical-TL System is substantially equivalent for its intended use. |